| Code No. | D204-4 | |
| Anti-CD52 (CAMPATH-1) (Mouse) mAb-FITC | ||
| Size | 100 µL (500 µg/mL) | |
| Availability (in Japan) | 10 or more
(In Japan at 17:00, Apr 14, 2026 in JST) |
|
| Clonality | Monoclonal | |
| Clone | BTG-2G | |
| Isotype (Immunized Animal) |
Rat IgG2aκ | |
| Applications | FCM 20 µg/mL (final concentration) |
|
| Immunogen (Antigen) |
mouse IL-2Ralpha-transgenic mice splenocytes | |
| Reactivity [Gene ID] | Mouse[23833] |
|
| Storage buffer | 500 µg/mL in PBS/1% BSA/0.1% ProClin150 | |
| Storage temp. | 4°C | |
| Conjugate | FITC | |
| Manufacturer | MBL | |
| Background | "CAMPATH-1, also known as CD52, is a heavily glycosylated, GPI-anchored protein expressed at high levels on almost all thymocytes, lymphocytes, monocytes, and macrophages. The function of CD52 is unknown. However, CD52 is an exceptionally good target for complement-mediated cell lysis and antibody-mediated cellular cytotoxicity. Humanized CAMPATH-1antibodies have been used therapeutically to effectively deplete lymphocytes in allogeneic bone marrow transplants, hematologic malignancies, and autoimmune diseases. Clinical trials suggest CAMPATH-1 antibodies are especially promising in the treatment of leukemia, non-Hodgkin lymphomas, and rheumatoid arthritis. The apparent size of CAMPATH-1 by SDS-PAGE is 25-29 kDa; however, the actual molecule is much smaller, ~ 8-9 kDa as confirmed by total structure analysis and mass spectrometry." | |
| Related products | D204-5 Anti-CD52 (CAMPATH-1) (Mouse) mAb-PE D204-3 Anti-CD52 (CAMPATH-1) (Mouse) mAb |
|
| Product category | Research area:Immunology Cancer Cell surface antigens | |
Copyright (C)2015 Medical & Biological Laboratories Co., Ltd. All Rights Reserve